IKZF1 and precursor B-cell acute lymphoblastic leukemia: In high-risk B-ALL, IKAROS’s ability to regulate MTOR expression is abolished due to deletion of one IKZF1 allele and phosphorylation of the IKAROS protein by oncogenic Casein Kinase II (CK2).